2015 annual financial data

XTL Biopharmaceuticals 2015 Financial results

Direct answer

Revenue was -6,000 USD.

Operating income was -3,611,000 USD and net income was -4,311,000 USD.
Operating cash flow was -1,861,000 USD.

Get free XTL Biopharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
-6,000 USD
Operating income
-3,611,000 USD
Net income
-4,311,000 USD
Operating cash flow
-1,861,000 USD